DUBLIN: : headquartered medical outsourcing provider Icon has reported a 3.4 per cent increase in revenues to $389 million (€352m) for the second quarter, compared to $376 million for the same quarter a year earlier.
First-half revenues at the Nasdaq-listed company rose 7.1 per cent to $776.9 million from $725.7 million.
Icon, which is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, said income from operations totalled was up 41 per cent year-on-year to $68.1 per cent, equivalent to 17.5 per cent of revenue as against $48.3 million or 12.8 per cent for the same quarter in 2014.